treatment of anti-neutrophil cytoplasmic antibody-associated vasculitis
All entries for: Otsuka Pharmaceutical Development & Commercialization, Inc
February 19, 2026
Otsuka Pharmaceutical Development & Commercialization, Inc
Orphan Drug Designation
Rockville
1-50 employees
Disease Area: Rare Diseases